Alcoholism and Mobility decreased

Summary:

Mobility decreased is found among people with Alcoholism, especially for people who are male, 40-49 old.

The study analyzes which people have Mobility decreased with Alcoholism. It is created by eHealthMe based on reports of 95 people who have Alcoholism from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Alcoholism?

Alcoholism (problems with alcohol) is found to be associated with 761 drugs and 1,353 conditions by eHealthMe. Check the latest studies of Alcoholism.

What is Mobility decreased?

Mobility decreased (ability to move is reduced) is found to be associated with 1,774 drugs and 1,632 conditions by eHealthMe. Check the latest studies of Mobility decreased.



On Jul, 18, 2026

95 people who have Alcoholism and Mobility Decreased are studied.

Would you have Mobility decreased when you have Alcoholism?

Gender of people who have Alcoholism and experienced Mobility Decreased *:

  • female: 25.81 %
  • male: 74.19 %

Age of people who have Alcoholism and experienced Mobility Decreased *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 5.8 %
  • 30-39: 26.09 %
  • 40-49: 37.68 %
  • 50-59: 20.29 %
  • 60+: 10.14 %

Common co-existing conditions for these people *:

  1. Drug Dependence: 8 people, 8.42%
  2. High Blood Pressure: 4 people, 4.21%
  3. Injection Site Mass: 3 people, 3.16%
  4. Depression: 2 people, 2.11%
  5. Injection Site Pain: 2 people, 2.11%
  6. Diabetes: 2 people, 2.11%
  7. Pain: 2 people, 2.11%
  8. Blood Folate Decreased: 1 person, 1.05%
  9. Blood Pressure Abnormal: 1 person, 1.05%
  10. Bipolar Disorder (mood disorder): 1 person, 1.05%

Common drugs taken by these people *:

  1. Vivitrol: 93 people, 97.89%
  2. Naltrexone: 6 people, 6.32%
  3. Seroquel: 4 people, 4.21%
  4. Wellbutrin: 3 people, 3.16%
  5. Xanax: 3 people, 3.16%
  6. Buspar: 2 people, 2.11%
  7. Lyrica: 2 people, 2.11%
  8. Singulair: 2 people, 2.11%
  9. Metformin: 2 people, 2.11%
  10. Proair Hfa: 2 people, 2.11%

Common symptoms for these people *:

  1. Injection Site Reaction: 67 people, 70.53%
  2. Injection Site Pain: 59 people, 62.11%
  3. Injection Site Mass: 29 people, 30.53%
  4. Pain: 19 people, 20.00%
  5. Injection Site Swelling: 17 people, 17.89%
  6. Injection Site Induration: 14 people, 14.74%
  7. Feeling Abnormal: 14 people, 14.74%
  8. Gait Disturbance: 12 people, 12.63%
  9. Joint Pain: 10 people, 10.53%
  10. Pain In Extremity: 9 people, 9.47%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Mobility decreased?

- Check whether Mobility decreased is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Mobility decreased:

All the conditions that are associated with Mobility decreased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Mobility decreased and Alcoholism, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: